Publikation

Beneficial Molecular Adaptations In -Mutation Carriers By Combined HIT/HIRT Intervention: Results From A Pilot Study

Wissenschaftlicher Artikel/Review - 10.06.2020

Bereiche
PubMed
DOI

Zitation
Bizjak D, Janni W, Huober J, Leinert E, Ebner F, Kirsten J, Otto S, Schumann U, Schulz S, Steinacker J. Beneficial Molecular Adaptations In -Mutation Carriers By Combined HIT/HIRT Intervention: Results From A Pilot Study. Cancers (Basel) 2020; 12
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Cancers (Basel) 2020; 12
Veröffentlichungsdatum
10.06.2020
ISSN (Druck)
2072-6694
Kurzbeschreibung/Zielsetzung

Based on growing evidence that breast cancer (BRCA) also plays a pivotal role in the regulation of skeletal muscle metabolism and the response to anti-oxidative stress, we examined the influence of regular exercise in human mutation carriers on their BRCA1 gene/protein expression and inflammatory/oxidative response. Sixteen -mutation carriers were assigned to an intervention (IG) or control group (CG). IG received a combination of high-intensity interval endurance (HIT) and strength training (HIRT) for six weeks, whereas CG received a low-intensity activity program. Before (T0) and at the end of the intervention (T1), muscle biopsy, physiological performance, blood withdrawal and anthropometry were obtained. Parameters included: Muscle BRCA1 gene/protein expression, inflammatory/oxidative stress, anti-oxidative capacity, peak oxygen capacity (VOpeak) and 1-repetition maximum (1-RM) at six different training machines. VOpeak and 1-RM of IG were increased at T1 compared to T0, whereas CG performance, physiological and molecular parameters remained unchanged. IG showed increased BRCA1 protein concentration as well as anti-oxidative capacity, whereas gene expression was unaltered. IG inflammatory and oxidative damage did not differ between time points. Combined HIT/HIRT increases aerobic and strength performance of -mutation carriers with up regulated BRCA1 protein expression and improved anti-oxidative status without showing an increased inflammatory response.